UNASSIGNED: The aim of the present study was to evaluate the clinical efficacy of @entity298 ( @entity298 ) in @entity1 with severe @entity1988 ( @entity1988 ) complicated with organ dysfunction. In total, 13 severe @entity1988 @entity1 complicated with @entity881 , who underwent @entity298 treatment between November 2003 and September 2010, were enrolled in the study. Six @entity1 received @entity1667 pulse therapy due to lupus activity and progressive @entity177 . These @entity1 were complicated with severe @entity4 , @entity299 and severe @entity4988 . @entity298 was applied to the @entity1 , followed by the administration of immunosuppressants. @entity1 were followed-up to review the parameters of renal function, the immunological indexes and the @entity1252 activity index. The results indicated that the general state of health was markedly improved following @entity298 treatment, with @entity4 abatement and improvement of heart function and physical strength. Serum @entity1011 levels significantly decreased from 6.3  1.6 to 2.6  1.0 mg/dl. A total of 10 cases ceased @entity298 treatment during the follow-up, while three cases continued @entity298 to the end of the follow-up period. The levels of albumin and hemoglobin exhibited a marked increase from 29.7  5.7 to 35.2  5.5 g/l and 8.7  1.8 to 9.8  1.8 g/l, respectively. There was one case of @entity298 , one case of peritoneal leakage and two cases of @entity55 . Therefore, @entity298 may be a successful treatment method for severe @entity1988 @entity1 complicated with essential organ dysfunction. @entity298 not only improved the symptoms of @entity4 and @entity712 , but also played an important role in preserving residual renal function and improving the nutritional state of the @entity1 . Thus, @entity298 can be considered as a treatment option for @entity1 with severe @entity1988 associated with @entity810 , however, selecting a suitable immunosuppressant during @entity298 treatment is essential.

Peritoneal dialysis treatment for severe XXXX @entity1 complicated with essential organ dysfunction.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1667 :: ('MESH:D008775', 'Chemical') :: ['methylprednisolone'] @entity712 :: ('MESH:D006333', 'Disease') :: ['heart failure'] @entity4988 :: ('MESH:D034141', 'Disease') :: ['hypoalbuminemia'] @entity55 :: ('MESH:D011014', 'Disease') :: ['pneumonia'] @entity4 :: ('MESH:D004487', 'Disease') :: ['edema'] @entity1252 :: ('MESH:D008180', 'Disease') :: ['systemic lupus erythematosus disease'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac insufficiency'] @entity1988 :: ('MESH:D008181', 'Disease') :: ['lupus nephritis', 'LN'] @entity177 :: ('MESH:D051437', 'Disease') :: ['renal failure'] @entity810 :: ('MESH:D058186', 'Disease') :: ['acute kidney injury'] @entity881 :: ('MESH:D009102', 'Disease') :: ['multiple-organ dysfunction'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity298 :: ('MESH:D010538', 'Disease') :: ['peritoneal dialysis', 'PD', 'peritonitis']
@entity1988 :: (MESH:D008181,Disease) :: ['lupus nephritis']
